Adams Diversified Equity Fund’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-75,700
Closed -$14.4M 221
2019
Q1
$14.4M Buy
+75,700
New +$14.5M 0.79% 55
2018
Q1
Sell
-113,300
Closed -$19.7M 213
2017
Q4
$19.7M Hold
113,300
1.06% 38
2017
Q3
$21.1M Sell
113,300
-13,700
-11% -$2.43M 1.15% 33
2017
Q2
$21.9M Hold
127,000
1.23% 30
2017
Q1
$20.8M Buy
127,000
+22,500
+22% +$3.74M 1.2% 32
2016
Q4
$15.3M Buy
+104,500
New +$15.7M 0.95% 41

Other funds holding AMGN

Adams Diversified Equity Fund's AMGN Position: Q2 2019 in Review

Adams Diversified Equity Fund sold out of Amgen (AMGN) in Q2 2019, closing a stake of 75,700 shares — an estimated $14.4M sold.

Adams Diversified Equity Fund first reported a position in AMGN in Q4 2016 and held it in 6 quarters. The position peaked at $21.9M in Q2 2017. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Adams Diversified Equity Fund reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Adams Diversified Equity Fund sold 75,700 Amgen shares in Q2 2019, an estimated $14.4M.
  • Adams Diversified Equity Fund first reported a position in Amgen in Q4 2016 and held it in 6 quarters.
  • Adams Diversified Equity Fund's Amgen position peaked at $21.9M in Q2 2017.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q2 2019, filed 29 Jul 2019.